Catalyst
Slingshot members are tracking this event:
Kite Expects First Patient Enrollment in 2017 for ZUMA-8 Trial Evaluating KTE-C19 in Chronic Lymphocytic Leukemia
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KITE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 09, 2018
Occurred Source:
https://clinicaltrials.gov/ct2/show/NCT03624036
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
First Patient Enrollment, Zuma-8, Kte-c19, Chronic Lymphocytic Leukemia
